AI-Enhanced Remote Neonatal Monitoring Market Report 2026

The artificial intelligence (AI)-enhanced remote neonatal monitoring market size has grown rapidly in recent years. It will grow from $1.27 billion in 2025 to $1.51 billion in 2026 at a compound annual growth rate (CAGR) of 18.9%. The growth in the historic period can be attributed to increasing premature birth rates, expansion of neonatal intensive care services, rising adoption of remote patient monitoring technologies, growing focus on early intervention in neonatal care, advancements in neonatal sensor technologies.

The artificial intelligence (AI)-enhanced remote neonatal monitoring market size is expected to see rapid growth in the next few years. It will grow to $2.98 billion in 2030 at a compound annual growth rate (CAGR) of 18.6%. The growth in the forecast period can be attributed to increasing adoption of ai-driven neonatal monitoring, rising demand for home-based neonatal care solutions, expansion of predictive health analytics, growing integration of cloud-based monitoring platforms, increasing focus on preventive neonatal healthcare. Major trends in the forecast period include increasing adoption of continuous neonatal vital monitoring, rising use of AI-based early warning systems, growing deployment of wearable neonatal sensors, expansion of remote neonatal care models, enhanced focus on predictive neonatal analytics.

The rising incidence of preterm births is expected to drive the growth of the artificial intelligence (AI)-enhanced remote neonatal monitoring market in the coming years. Preterm birth refers to infants born before 37 completed weeks of gestation, often requiring specialized medical care due to underdeveloped organs, and is a major factor influencing neonatal health outcomes. The incidence of preterm births is increasing as more women are having children at older ages, which raises the risk of pregnancy complications and early delivery. AI-enhanced remote neonatal monitoring supports the management of preterm births by continuously analyzing vital signs to detect early complications, enabling timely interventions and safer post-discharge care. For example, in March 2025, the Centers for Disease Control and Prevention (CDC), a US-based nonprofit organization, reported that the U.S. preterm birth rate rose to 10.41% in 2023, slightly up from 10.38% in 2022. Consequently, the rising incidence of preterm births is fueling the growth of the AI-enhanced remote neonatal monitoring market.

Key companies in the AI-enhanced remote neonatal monitoring market are developing advanced solutions such as AI-driven neonatal and pediatric care monitoring platforms to improve early detection of health complications, enhance clinical decision-making, and enable continuous real-time monitoring of newborns. These platforms use AI to track and analyze newborns’ and children’s health data, detect anomalies, and provide actionable insights for timely intervention. For instance, in April 2025, AngelEye Health, a US-based provider of neonatal and pediatric family engagement technology, launched AIVision, which integrates AI and computer vision into neonatal intensive care units (NICUs) and pediatric units. The platform transforms existing bedside cameras into intelligent clinical tools that provide proactive, data-driven insights to clinical teams. Key features include AI-powered motion analysis for early neuromotor risk detection, video EEG synchronization, respiratory status monitoring for early signs of distress, AI-assisted pain and sedation assessment, and crash/coding event recording to support clinical training.

In September 2024, Samsung Medison, a South Korea-based provider of diagnostic ultrasound systems and medical imaging solutions, acquired Sonio SAS for approximately $92.4 million. This acquisition aims to strengthen Samsung Medison’s prenatal care offerings by integrating Sonio’s advanced AI-assisted ultrasound reporting and workflow solutions into its systems, improving clinical accuracy and efficiency in maternal healthcare. Sonio SAS is a France-based provider of AI-driven ultrasound software solutions designed to assist clinicians in evaluating and documenting obstetric and gynecological ultrasound exams, including AI-enhanced remote neonatal monitoring.

Major companies operating in the artificial intelligence (AI)-enhanced remote neonatal monitoring market are Philips Healthcare, GE HealthCare Technologies Inc., Mount Sinai Health System Inc., Mindray Medical International Limited, Drägerwerk AG & Co. KGaA, Hill-Rom Company Inc., Masimo Corporation, Sheba Medical Center, Natus Medical Incorporated, Spacelabs Healthcare Inc., Aver Information Inc., Owlet Inc., Nanit Inc., AngelEye Health Inc., Raybaby Inc., Zoundream Inc., Sempulse Inc., Kriba Inc., Luscii B.V., Bloomlife Inc.

North America was the largest region in the artificial intelligence (AI)-enhanced remote neonatal monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-enhanced remote neonatal monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence (AI)-enhanced remote neonatal monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the AI-enhanced remote neonatal monitoring market by increasing costs of imported sensors, wearable devices, communication modules, and cloud infrastructure hardware. Healthcare systems in North America and Europe are most affected due to dependence on imported neonatal monitoring equipment, while Asia-Pacific faces higher production and export costs. These tariffs are increasing implementation expenses and slowing adoption in homecare settings. However, they are also encouraging domestic device manufacturing, regional software innovation, and localized deployment of neonatal monitoring solutions.

The artificial intelligence (AI)-enhanced remote neonatal monitoring market research report is one of a series of new reports that provides artificial intelligence (AI)-enhanced remote neonatal monitoring market statistics, including artificial intelligence (AI)-enhanced remote neonatal monitoring industry global market size, regional shares, competitors with a artificial intelligence (AI)-enhanced remote neonatal monitoring market share, detailed artificial intelligence (AI)-enhanced remote neonatal monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced remote neonatal monitoring industry. This artificial intelligence (AI)-enhanced remote neonatal monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial intelligence (AI)-enhanced remote neonatal monitoring is an advanced system that uses AI algorithms to continuously analyze and interpret vital signs and physiological data of newborns, particularly those who are premature or high-risk, outside traditional hospital settings. It enables predictive analysis and early detection of potential health issues, supporting timely and informed monitoring of neonatal health.

The main components of AI-enhanced remote neonatal monitoring include hardware, software, and services. Hardware consists of wearable sensors, biosensors, and wireless modules that continuously track newborns’ vital signs. Monitoring types include vital signs, respiratory, cardiac, and others. These systems are deployed through cloud-based and on-premises models. Key end-users include hospitals, neonatal intensive care units, homecare settings, clinics, and other healthcare facilities.

The artificial intelligence (AI)-enhanced remote neonatal monitoring market consists of revenues earned by entities by providing services such as continuous vital signs monitoring, predictive health analytics, remote data transmission, personalized care recommendations, and trend analysis and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced remote neonatal monitoring market also includes sales of smart wearables for neonates, nutrition monitors, and neonatal imaging systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.